⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S3 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes

Ji‐Qing Chen Lucas A. Salas John K. Wiencke Devin C. Koestler Annette M. Molinaro Angeline S. Andrew John D. Seigne Margaret R. Karagas Karl T. Kelsey Brock C. Christensen

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S3: Semi-Supervised Recursively Partitioned Mixture Model (SS-RPMM) for 10-year overall survival (OS) in NMIBC patients [For Hannum age acceleration]

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522c3f https://doi.org/10.1158/1055-9965.27030178.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes2024
2Supplementary Figure S5 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes2024
3Supplementary Figure S5 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes2024
4Supplementary Figure S4 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes2024
5Supplementary Figure S4 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes2024

Supplementary Figure S2 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes2024
Supplementary Figure S2 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes2024
Supplementary Figure S1 from Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes2024